Aethlon Medical
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Aethlon Medical generated cash of -$10,129,810, which is more than the previous year. Cash used in financing activities reached the amount of $1,287,605 last year. Net change in cash is therefore -$9,090,965.
Cash Flow
| 2015 | -5.04M | -96K | 4.65M |
|---|---|---|---|
| 2016 | -4.32M | -9.30K | 5.60M |
| 2017 | -3.50M | -16.43K | 2.95M |
| 2018 | -3.91M | -24.82K | 9.34M |
| 2019 | -4.29M | 0 | 1.14M |
| 2020 | -5.19M | -151.66K | 11.12M |
| 2021 | -6.76M | -59.88K | 7.12M |
| 2022 | -9.76M | -349.19K | 17.36M |
| 2023 | -10.50M | -943.10K | 8.91M |
| 2024 | -10.12M | -250.86K | 1.28M |
AEMD Cash Flow Statement (2015 – 2024)
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 14.62M | 17.15M | 9.90M | 9.60M | 3.82M | 6.97M | 1.55M | 2.12M | 855.59K | 1.25M |
Operating activities | ||||||||||
Net income | -12.20M | -12.02M | -10.42M | -7.89M | -6.38M | -6.21M | -5.69M | -7.30M | -4.95M | -6.97M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 359.05K | 240.89K | 123.68K | 39.93K | 26.36K | 30.69K | 35.65K | 32.41K | 38.52K | 37.35K |
Stock-based compensation expense | 1.21M | 1.05M | 750.62K | 779.42K | 843.99K | 1.31M | 1.26M | 2.18M | 202.84K | 416.48K |
| Deferred income tax benefit | 1.21M | 1.05M | 750.62K | 779.42K | 843.99K | 1.31M | 1.26M | 2.18M | 202.84K | 416.48K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 127.96K | 21.11K | 57.64K | -206.72K | 74.81K | -74.81K | 199.47K | 0 | -98.16K |
Inventories | 0 | 456.64K | 0 | -104.66K | 8.49K | -74.81K | -6.86M | 0 | 0 | 0 |
Accounts payable | 156.67K | -174.72K | 97.54K | 341.85K | -16.76K | 390.34K | -104.15K | 322.14K | -46.36K | -1.10M |
Cash generated by operating activities | -10.12M | -10.50M | -9.76M | -6.76M | -5.19M | -4.29M | -3.91M | -3.50M | -4.32M | -5.04M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -250.86K | -943.10K | -349.19K | -59.88K | -151.66K | 0 | -24.82K | -16.43K | -9.30K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -250.86K | -943.10K | -349.19K | -59.88K | -151.66K | 0 | -24.82K | -16.43K | -9.30K | -96K |
Financing activities | ||||||||||
Common Stock Issued | 1.32M | 8.92M | 17.45M | 7.26M | 12.15M | 1.34M | 9.62M | 2.75M | 5.60M | 4.76M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | -132.52K | -40.93K | -193.86K | -278.63K | -378.51K | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | -992.59K | 0 | 0 | 577.46K | 0 | -108.42K |
Cash used in financing activities | 1.28M | 8.91M | 17.36M | 7.12M | 11.12M | 1.14M | 9.34M | 2.95M | 5.60M | 4.65M |
Net Change In Cash | -9.09M | -2.53M | 7.25M | 303.52K | 5.77M | -3.14M | 5.41M | -564.03K | 1.26M | -394.68K |
Cash at end of period | 5.52M | 14.62M | 17.15M | 9.90M | 9.60M | 3.82M | 6.97M | 1.55M | 2.12M | 855.59K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |